Literature DB >> 13115641

Dextran sulphate: the relation of molecular features to biological properties.

C R RICKETTS, K W WALTON.   

Abstract

Entities:  

Keywords:  DEXTRAN

Mesh:

Substances:

Year:  1953        PMID: 13115641      PMCID: PMC1509356          DOI: 10.1111/j.1476-5381.1953.tb01351.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


× No keyword cloud information.
  2 in total

1.  Experiments with dextran sulphate as an anticoagulant.

Authors:  K WALTON
Journal:  Proc R Soc Med       Date:  1951-07

2.  Dextran sulphate--a synthetic analogue of heparin.

Authors:  C R RICKETTS
Journal:  Biochem J       Date:  1952-04       Impact factor: 3.857

  2 in total
  7 in total

1.  Morphologic changes in rabbits following the intravenous administration of meningococcal toxin. III. The effects produced by endotoxin in association with certain high molecular weight acidic polymers.

Authors:  J G BRUNSON; R L DAVIS; L THOMAS
Journal:  Am J Pathol       Date:  1955 Jul-Aug       Impact factor: 4.307

2.  The production of lipolytic activity in rat plasma after the intravenous injection of dextran sulphate.

Authors:  D S ROBINSON; P M HARRIS; C R RICKETTS
Journal:  Biochem J       Date:  1959-02       Impact factor: 3.857

3.  Duration of anticoagulant effect in relation to urinary excretion of dextran sulphate.

Authors:  S M JEAVONS; C R RICKETTS; K W WALTON
Journal:  Br Med J       Date:  1956-11-03

4.  Preparation of dextran [35S] sulphate and tracer experiments in the rabbit.

Authors:  C R RICKETTS; K W WALTON; S M SADDINGTON
Journal:  Biochem J       Date:  1954-12       Impact factor: 3.857

5.  Investigation of the toxicity of a series of dextran sulphates of varying molecular weight.

Authors:  K W WALTON
Journal:  Br J Pharmacol Chemother       Date:  1954-03

6.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1956-11-17

7.  The prevention of the generalized Shwartzman reaction with sodium warfarin.

Authors:  S S SHAPIRO; D G McKAY
Journal:  J Exp Med       Date:  1958-03-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.